sibo glp-1 ACG 2025 Annual Meeting Posters sibo and glp 1 New

Description

This gives you targeted, higher-dose coverage of the specific nutrients GLP-1 users are most likely to be deficient in (Urbina 2026), plus a digestive comfort layer that no multivitamin includes

In a 16-week placebo-controlled study, participants using SLENDACOR alongside diet and exercise lost an average of 12 pounds and achieved results that were 6 times greater than diet and exercise alone. MyGLP-1 ProClinical delivers a comprehensive, stimulant-free approach to weight management and metabolic health

Despite the companys claim that their product promotes appetite control,

This acceleration coincided with surging demand for semaglutide and tirzepatide, two therapies that have become synonymous with the new era of diabetes and obesity treatment